Literature DB >> 27420136

Explanatory models of muscle performance in acromegaly patients evaluated by knee isokinetic dynamometry: Implications for rehabilitation.

Agnaldo José Lopes1, Arthur Sá Ferreira2, Evelyn Mendes Walchan3, Mauricio Santos Soares4, Priscila Santos Bunn5, Fernando Silva Guimarães6.   

Abstract

PURPOSE: To evaluate the effects of demographics and hormonal variations on knee muscle performance in patients with acromegaly and develop explanatory models of peripheral muscle function in these individuals.
METHODS: This was a cross-sectional study in which 53 acromegalics and 27 healthy subjects underwent knee isokinetic dynamometry to evaluate the peak torque value for leg extension at 75°/s (PTE75) and 240°/s (PTE240). Separate multivariable linear regression models for the prediction of PTE75 and PTE240 were tested using variables commonly used as predictors in the clinical setting and other specific variables related to acromegaly.
RESULTS: The final prediction model for PTE75 (R(2)=0.888; adjusted R(2)=0.820, SE of bias=16.2Nm, p<0.001) was -0.221×growth hormone+36.791×sexmale=1-27.407×statusactive=1-0.690×age+148.071. The final prediction model for PTE240 (R(2)=0.816; adjusted R(2)=0.805, SE of bias=8.8Nm, p<0.001) was -0.174×growth hormone+12.522×sexmale=1-0.520×age+98.099.
CONCLUSIONS: In acromegalics, high growth hormone levels, female gender, and older age are associated with reduced muscle strength and endurance. Additionally, active disease negatively affects peripheral muscle strength in these patients.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Acromegaly; Muscle strength; Rehabilitation

Mesh:

Year:  2016        PMID: 27420136     DOI: 10.1016/j.humov.2016.07.005

Source DB:  PubMed          Journal:  Hum Mov Sci        ISSN: 0167-9457            Impact factor:   2.161


  3 in total

Review 1.  Musculoskeletal Effects of Altered GH Action.

Authors:  Jonathan A Young; Shouan Zhu; Edward O List; Silvana Duran-Ortiz; Yosri Slama; Darlene E Berryman
Journal:  Front Physiol       Date:  2022-05-19       Impact factor: 4.755

2.  Body Composition Changes with Long-term Pegvisomant Therapy of Acromegaly.

Authors:  Adriana P Kuker; Wei Shen; Zhezhen Jin; Simran Singh; Jun Chen; Jeffrey N Bruce; Pamela U Freda
Journal:  J Endocr Soc       Date:  2021-02-01

3.  The acromegaly lipodystrophy.

Authors:  Pamela U Freda
Journal:  Front Endocrinol (Lausanne)       Date:  2022-09-13       Impact factor: 6.055

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.